Skip to main content
Paramala Santosh

Professor Paramala Santosh

Professor of Developmental Neuropsychiatry and Psychopharmacology

Biography

Professor Paramala Santosh, MBBS, Dip NB (Psych), MD, Ph.D, FRCPsych is a Consultant Child & Adolescent Psychiatrist at the Maudsley Hospital, and Professor in Developmental Neuropsychiatry and Psychopharmacology at the Institute of Psychiatry, Psychology & Neurosciences (IoPPN), King’s College London. He developed and heads the national and specialist Centre for Interventional Paediatric Psychopharmacology Research Team (CIPPRT), and the CIPP Rett Centre. The CIPP Rett Centre is the world’s first centre for personalised medicine in Rett Syndrome. Professor Santosh also co-developed the GDPR compliant HealthTrackerTM platform for remote screening, patient reported outcome monitoring, and structured medication review and is the CEO of the SME HealthTracker Ltd.

Professor Santosh is an internationally recognised expert in paediatric psychopharmacology, treatment-resistant developmental multimorbidity, and neuropsychiatric problems in acquired brain injury, childhood dementias, and rare diseases such as Rett syndrome, Septo-Optic Dysplasia, Mucopolysaccharidoses, and paediatric neurodegeneration. His research focusses on translational personalised medicine approaches using remote digital health monitoring, structured pharmacological approaches, sensor-based psychophysiological monitoring, and machine learning.

Research Interests

  • Rett Syndrome
  • ADHD
  • ASD
  • Digital health monitoring

Research Groups

  • Member - European ADHD Guideline Group (EAGG)

Expertise and Public Engagement

  • Committee Member – RCPsych Child & Adolescent Psychiatry Executive Committee
  • Editorial Advisor – BMC Pediatrics

Teaching

  • MSc in Child and Adolescent Mental Health - supervision of individual clinical placements and research projects

Research

pharmacology
Centre for Interventional Paediatric Psychopharmacology Research Team (CIPPRT)

CIPPRT is a team focused on medication-related suicidality, development of Patient Center Outcome Measures (PCOMs), as well as rare diseases such as Rett syndrome and mucopolysaccharidoses (MPS) syndrome.

pexels-anna-shvets-4226219-min
ATTENS Project

The ATTENS Project explores the potential of eTNS in improving symptoms, cognitive performance and the functioning of the brain in children with ADHD.

Project status: Ongoing

Children of UPBEAT

To study heart and blood vessel health in children born to mothers with obesity who had participated in the UK Pregnancies Better Eating and Activity Trial.

Project status: Ongoing

News

IoPPN researchers announced winners of the 2022 ACAMH Awards

Several researchers at the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) won awards at the Association for Child and Adolescent Mental Health...

star

Research

pharmacology
Centre for Interventional Paediatric Psychopharmacology Research Team (CIPPRT)

CIPPRT is a team focused on medication-related suicidality, development of Patient Center Outcome Measures (PCOMs), as well as rare diseases such as Rett syndrome and mucopolysaccharidoses (MPS) syndrome.

pexels-anna-shvets-4226219-min
ATTENS Project

The ATTENS Project explores the potential of eTNS in improving symptoms, cognitive performance and the functioning of the brain in children with ADHD.

Project status: Ongoing

Children of UPBEAT

To study heart and blood vessel health in children born to mothers with obesity who had participated in the UK Pregnancies Better Eating and Activity Trial.

Project status: Ongoing

News

IoPPN researchers announced winners of the 2022 ACAMH Awards

Several researchers at the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) won awards at the Association for Child and Adolescent Mental Health...

star